• Filing Date: 2018-05-10
  • Form Type: 10-Q
  • Description: Quarterly report
v3.8.0.1
Stockholders' Equity (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Aug. 11, 2017
USD ($)
$ / shares
shares
Jul. 28, 2017
USD ($)
director
$ / shares
shares
Sep. 01, 2015
USD ($)
Feb. 11, 2011
shareholder
$ / shares
shares
Oct. 31, 2014
$ / shares
Apr. 30, 2014
USD ($)
shares
Mar. 31, 2018
USD ($)
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Dec. 31, 2017
USD ($)
shares
Jul. 17, 2017
shares
Jun. 30, 2017
shares
Jun. 27, 2017
shares
Stockholders Equity [Line Items]                        
Options outstanding (in shares)             239,000   542,102      
Share and note repurchase program, authorized amount | $     $ 10,000,000                  
Stock repurchase program, term of plan     2 years                  
Cost of shares acquired | $             $ 2,534,000 $ 2,500,000 $ 2,534,000 [1]      
Average cost per share (in dollars per share) | $ / shares               $ 4.17        
Stock repurchased | $             0          
Common stock issued | $             $ 9,000          
Common stock, shares authorized (in shares)             415,000,000   415,000,000 [1] 415,000,000 80,000,000  
Number of board of directors | director   7                    
Common Stock Purchase Agreement                        
Stockholders Equity [Line Items]                        
Sale of stock, number of shares issued (in shares)   115,000,000                    
Sale of stock, price per share (in dollars per share) | $ / shares   $ 0.20                    
Common stock issued | $   $ 23,000,000                    
Immediately Upon Issuance | Convertible Notes                        
Stockholders Equity [Line Items]                        
Warrants issued (in shares)   17,500,000                    
At Later Times After Conversion of Notes | Convertible Notes                        
Stockholders Equity [Line Items]                        
Warrants issued (in shares)   25,000,000                    
Term of warrants   8 years                    
Warrant Investors                        
Stockholders Equity [Line Items]                        
Exercise price of warrants (in dollars per share) | $ / shares   $ 0.2                    
Warrants issued (in shares)   42,500,000                    
PJC, Triax and Other Affiliates                        
Stockholders Equity [Line Items]                        
Warrants issued (in shares)   27,150,000                    
Sale of stock, number of shares issued (in shares)   39,320,038                    
PJC, Triax and Other Affiliates | Emergent Capital, Inc.                        
Stockholders Equity [Line Items]                        
Percentage of ownership after sale of stocks (as percent)   38.90%                    
PJC, Triax and Other Affiliates | Common Stock Purchase Agreement                        
Stockholders Equity [Line Items]                        
Sale of stock, number of shares issued (in shares)   75,000,000                    
Common stock issued | $   $ 15,000,000                    
Convertible Notes Holders Investors | Common Stock Purchase Agreement                        
Stockholders Equity [Line Items]                        
Sale of stock, number of shares issued (in shares)   40,000,000                    
Common stock issued | $   $ 8,000,000                    
PJC Investments, LLC | Common Stock Purchase Agreement                        
Stockholders Equity [Line Items]                        
Sale of stock, number of shares issued (in shares)   19,320,038                    
Brennan | Common Stock Purchase Agreement                        
Stockholders Equity [Line Items]                        
Securities remaining for future issuance (in shares) 12,500,000                      
Sale of stock, price per share (in dollars per share) | $ / shares $ 0.40                      
Sale of stock, aggregate purchase price | $ $ 5,000,000                      
Other Investors Designated by PJC and Triax                        
Stockholders Equity [Line Items]                        
Warrants issued (in shares)   13,350,000                    
Sale of stock, number of shares issued (in shares)   55,000,000                    
Other Investors Designated by PJC and Triax | Emergent Capital, Inc.                        
Stockholders Equity [Line Items]                        
Percentage of ownership after sale of stocks (as percent)   43.60%                    
USAO Investigation                        
Stockholders Equity [Line Items]                        
Exercise price of warrants (in dollars per share) | $ / shares         $ 10.75              
Litigation settlement, shares to escrow (in shares)           2,000,000            
Estimated fair value of warrants | $           $ 5,400,000            
Common stock warrants term         5 years              
Average daily trading closing price (in dollars per share) | $ / shares         $ 8.50              
Average daily trading closing price, period         45 days              
Over-Allotment Option                        
Stockholders Equity [Line Items]                        
Number of shareholders | shareholder       3                
Warrants issued (in shares)       4,240,521                
Exercise price of warrants (in dollars per share) | $ / shares       $ 14.51                
Warrant expiration period       7 years                
Treasury Stock                        
Stockholders Equity [Line Items]                        
Antidilutive securities excluded from computation of diluted earnings per share (in shares)               608,000        
Restricted Stock                        
Stockholders Equity [Line Items]                        
Stock granted (in shares)             100,000          
Shares pending vesting (in shares)             2,182,522   2,102,522      
Omnibus Plan                        
Stockholders Equity [Line Items]                        
Shares of common stock reserved for future grant (in shares)                       12,600,000
Securities remaining for future issuance (in shares)             9,953,785          
Omnibus Plan | Stock Options                        
Stockholders Equity [Line Items]                        
Options outstanding (in shares)             239,000          
Omnibus Plan | Restricted Stock                        
Stockholders Equity [Line Items]                        
Shares pending vesting (in shares)             2,182,522          
Omnibus Plan | Restricted Stock | Directors                        
Stockholders Equity [Line Items]                        
Stock granted (in shares)             233,215          
Omnibus Plan | Restricted Stock | Certain Employees                        
Stockholders Equity [Line Items]                        
Stock granted (in shares)             8,522          
Omnibus Plan | Restricted Stock Units (RSUs) | Certain Employees                        
Stockholders Equity [Line Items]                        
Stock granted (in shares)             2,174,000          
[1] Derived from audited consolidated financial statements.